Characteristics Associated with Biologic Monotherapy Use in Biologic-Naive Patients with Rheumatoid Arthritis in a US Registry Population.
about
Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial.Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trials.Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs.Patient Satisfaction with Pharmacist-Led Collaborative Follow-Up Care in an Ambulatory Rheumatology Clinic.Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases
P2860
Characteristics Associated with Biologic Monotherapy Use in Biologic-Naive Patients with Rheumatoid Arthritis in a US Registry Population.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Characteristics Associated wit ...... s in a US Registry Population.
@en
type
label
Characteristics Associated wit ...... s in a US Registry Population.
@en
prefLabel
Characteristics Associated wit ...... s in a US Registry Population.
@en
P2093
P2860
P1476
Characteristics Associated wit ...... s in a US Registry Population.
@en
P2093
Ashwini Shewade
Dimitrios A Pappas
George W Reed
Jeffrey D Greenberg
Joel M Kremer
Katherine Saunders
P2860
P2888
P356
10.1007/S40744-015-0008-9
P577
2015-01-27T00:00:00Z